TCL Archive J&J To Eliminate Its Ortho Biotech Unit As FDA Considers Further Limits On ESAs. May 2, 2008
TCL Archive FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention” November 6, 1998
TCL Archive Congress Agrees On Jackson Lab Support, But does Not Add Money; Earmarks Hit NCI Budget October 27, 1989
